Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07508241 · ClinicalTrials.gov registry record · Phase 1
A Study to Learn About the Effect of Study Medicine Called PF-08653944 on How Quickly the Stomach Empties Its Content in Healthy Adults With Overweight or Obesity
A Phase 1 study, sponsored by Pfizer.
- Active
- Registry status
- Phase 1
- Development phase
- 22
- Enrollment target
NCT07508241 is a Phase 1 study that is active but no longer recruiting, run by Pfizer. The registered enrollment target is 22 participants.
The verdict
NCT07508241, a Phase 1 study, is active but no longer recruiting, sponsored by Pfizer.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 22 participants
- Enrollment target
Study Summary
This study looks at how a study medicine called PF-08653944 affects how quickly the stomach empties food after eating. It is being done in adults who are overweight or have obesity. Participants will receive the study medicine for a short period, and doctors will measure how the medicine moves through the stomach and monitor safety. The goal is to better understand how this medicine works in the body and to check for any side effects. The information from this study may help researchers plan future studies of this medicine.
Interventions
- DRUG Acetaminophen
- DRUG PF-08653944
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2026-03-31 |
| Est. Completion | 2027-01-27 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07508241
The ClinicalTrials.gov registry entry for NCT07508241 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acetaminophen is the first listed.
NCT07508241 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07508241 about?
NCT07508241 is a clinical study titled "A Study to Learn About the Effect of Study Medicine Called PF-08653944 on How Quickly the Stomach Empties Its Content in Healthy Adults With Overweight or Obesity". This study looks at how a study medicine called PF-08653944 affects how quickly the stomach empties food after eating. It is being done in adults who are overweight or have obesity. Participants will receive the study medicine for a short period, and doctors will measure how the medicine moves thro...
What is the current status of trial NCT07508241?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2026-03-31. Estimated completion is 2027-01-27.
What interventions are being tested in trial NCT07508241?
The interventions under investigation include: Acetaminophen (DRUG), PF-08653944 (DRUG).
Who is sponsoring clinical trial NCT07508241?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.